Interpretation of the Juvenile Arthritis Disease Activity Score: Responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis

Rheumatology (United Kingdom)

Volumn 53, Issue 2, 2014, Pages 307-312

  Ćalasan, Maja Bulatović ^a   De vries, Lara D ^a   Vastert, Sebastiaan J ^a   Heijstek, Marloes W ^a   Wulffraat, Nico M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Clinically important difference; Disease activity; Juvenile idiopathic arthritis; Responsiveness

Indexed keywords

ARTICLE; CHILD; COHORT ANALYSIS; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DISEASE SEVERITY; EFFECT SIZE; FEMALE; HUMAN; JUVENILE ARTHRITIS DISEASE ACTIVITY SCORE 27; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

CLINICALLY IMPORTANT DIFFERENCE; DISEASE ACTIVITY; JUVENILE IDIOPATHIC ARTHRITIS; RESPONSIVENESS;

ADOLESCENT; ARTHRITIS, JUVENILE; CHILD; CHILD, PRESCHOOL; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84892548910     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket310     Document Type: Article

References (15)

1. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767-78.
2. Hashkes PJ, Laxer RM. Medical treatment of juvenile idiopathic arthritis. JAMA 2005;294:1671-84.
3. Consolaro A, Ruperto N, Bazso A et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 2009;61:658-66.
4. Felson DT, Smolen JS, Wells G et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 2011;70:404-13.
5. Emery P, Kvien TK, Combe B et al. Combination etanercept and methotrexate provides better disease control in very early (<=4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study. Ann Rheum Dis 2012;71:989-92.
6. Petty RE, Southwood TR, Manners P et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
7. Wulffraat N, van der Net JJ, Ruperto N et al. The Dutch version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001;19:S111-5.
8. Revicki DA, Cella D, Hays RD et al. Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes 2006;4:70.
9. Ruperto N, Ravelli A, Falcini F et al. Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group. Ann Rheum Dis 1998;57:38-41.
10. Brunner HI, Lovell DJ, Finck BK et al. Preliminary definition of disease flare in juvenile rheumatoid arthritis. J Rheumatol 2002;29:1058-64.
11. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003;56:395-407.
12. Copay AG, Subach BR, Glassman SD et al. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J 2007;7:541-6.
13. Deyo RA, Inui TS. Toward clinical applications of health status measures: sensitivity of scales to clinically important changes. Health Serv Res 1984;19: 275-89.
14. van Gestel AM, Prevoo ML, van't Hof MA et al. Development and validation of the European league against rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996;39:34-40.
15. Consolaro A, Bracciolini G, Ruperto N et al. Remission, minimal disease activity and acceptable symptom state in juvenile idiopathic arthritis. Arthritis Rheum 2012;64: 2366-74.